Evidence map›Paper›PMID 34020272›Full record

Trial reportBlood cells, molecules & diseases2021

Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response.

Alina Sadaf, Charles T Quinn, Jennifer B Korpik, Amanda Pfeiffer, Mary Reynaud, Omar Niss, Punam Malik, Russell E Ware, Theodosia A Kalfa, Patrick T McGann

Abstract readClinical TrialLetter
In one paragraph

Trial report in Blood cells, molecules & diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alina SadafCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.
Charles T QuinnCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Erythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Jennifer B KorpikErythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.
Amanda PfeifferDivision of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.
Mary ReynaudErythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.
Omar NissCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Punam MalikCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Russell E WareCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Theodosia A KalfaCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Erythrocyte Diagnostic Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Patrick T McGannCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America. Electronic address: patrick.mcgann@cchmc.org.

Funding

Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell AnemiaK23HL128885 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MCGANN, PATRICK THOMAS · 2015 to 2019
$910k
NHLBI NIH HHS K23 HL128885
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellAntisickling AgentsHydroxyureaAdolescentBiomarkersChildChild, PreschoolErythrocytesFemaleHemoglobin, SickleHumansInfantMaleAntisickling AgentsBiomarkersHemoglobin, SickleHydroxyureaBiomarkersHydroxyureaMCHCSickle cell anemia

Identifiers

PMID34020272
PMCPMC8829804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.